This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
26 Mar 2021 | North America | Customer Research
Global Laboratory Product Purchasing Trends, 2020–2021
An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents yea...
$4,950.00 -
18 Dec 2015 | Global | Technology Alert
Medical Imaging—Toward Deep-Rooted Cancer Cell Imaging - Medical and Diagnostic Imaging Technology
This issue profiles cancer cell imaging technologies.
$950.00 -
11 Dec 2015 | Global | Technology Alert
Futuretech TechVision Opportunity Engine--Therapeutics Devices (Non-Drug) for Sleep Apnea
This issue profiles technology advances and trends for the treatment of sleep apnea.
$750.00 -
27 Nov 2015 | Global | Technology Alert
Medical and Diagnostic Imaging Technology TechVision Opportunity Engine--Innovating toward Enhanced Medical Imaging Platforms
This edition profiles innovations aimed at producing enhanced medical imaging platforms.
$950.00 -
30 Oct 2015 | Global | Technology Alert
Medical And Diagnostic Imaging Technology--Medical Imaging Leading the Way to Better Diagnosis
This alert profiles medical imaging technologies that enable better diagnosis.
$950.00 -
This issue profiles a novel blood pumping device to aid heart failure patients, an ultrasound diagnostic tool for bone strength assessment, and a wearable maternal-fetal monitor to improve prenatal health.
$950.00 -
This issue profiles development of a triboelectric nanogenerator, biomechanical energy harvesting with piezoelectric nanogenerators, and chemotherapy enabled by nanoparticles treats cancer stem-like cells.
$250.00 -
This issue profiles a high-priced hepatitis c drug that results in development of generic products, a rapid antigen test for Ebola, and focused antiviral clinical programs for infectious diseases.
$250.00 -
This issue profiles an imaging app for ultrasound, a compatible leads for MRI systems, and innovative contrast agents for preclinical imaging.
$950.00 -
This issue profiles a drug for oculopharyngeal muscular dystrophy treatment that receives orphan drug designation; non-viral CFTR-based gene therapy for cystic fibrosis patients, a breast cancer diagnostic test in Europe.
$250.00
